Lifespan
David A. Sinclair · 2019 · 10 ideas · 10 min
Aging is not an inevitable, immutable fact of biology but a treatable disease driven by a loss of cellular information, and emerging science suggests we may be able to slow or even reverse it.
Why this book
David Sinclair, a Harvard geneticist, argues that aging should be reclassified as a disease rather than accepted as a natural, untouchable process — one governed by a specific and increasingly well-understood mechanism: cells gradually losing the epigenetic information that tells them how to function properly, much like a scratched CD losing fidelity even though the underlying data is still there. He surveys decades of research on longevity genes, caloric restriction, and molecules like NAD+ boosters and rapamycin, alongside his own lab's work, to argue that meaningfully extending healthy human lifespan is a realistic, near-term scientific goal rather than science fiction.
The book matters because it reframes aging research from a niche curiosity into what Sinclair argues should be medicine's central priority, since delaying aging itself could simultaneously delay the onset of most major age-related diseases — cancer, heart disease, dementia — rather than treating each separately after the fact.
Who should read it
Readers interested in longevity science who want the underlying biology explained rather than just supplement recommendations, and anyone curious about the serious (if still unproven at scale) research suggesting aging itself might become medically treatable.
About the author
David A. Sinclair is a professor of genetics at Harvard Medical School who has researched the biology of aging for over two decades, with particular focus on sirtuins and NAD+ metabolism.